Hepatitis Weekly
Susan Hasty, Publisher
Table of Contents . . . October 10th, 2005
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Chronic Hepatitis C - Peginterferon alpha dosing strategies beat persistent hepatitis C
Diagnostics - A new rapid test for hepatitis E enhances point-of-care testing
Diagnostics - Combination assay improves early detection of hepatitis C virus infection
Diagnostics - Plasma chemokine levels predict hepatitis C response to antiviral therapy
Oncology - Interferon limits genetic instability in livers infected with hepatitis C
Adverse Drug Reaction - Combination therapy containing pegylated interferon produces weight loss
Allergy & Immunology - Antibody to transglutaminase denotes the presence of chronic liver diseases
Autoimmune Hepatitis - Inadequate regulatory T-cell activity may initiate liver injury
Biomedical Engineering - Spheroid reservoir bioartificial liver rapidly produces hepatocyte spheroids
Cancer Prevention - Interferon-alpha lowers proliferative activity in hepatitis C-infected livers
Chronic Hepatitis B - Hepatitis B virus genotype C mutations accompany poor liver histology
Diagnostics - Reports advance knowledge in diagnostics research
Chronic Liver Disease - Bacterial pathogens may be involved in the onset of primary biliary cirrhosis
Chronic Liver Disease - Response to corticosteroid hails good outcomes in severe alcoholic hepatitis
Diagnostics - Data advance knowledge in diagnostics research
Diagnostics - Degenerate primers pinpoint multiple genotypes of woodchuck hepatitis virus
Diagnostics - Dipstick assay offers visual detection of multiple nucleic acid amplicons
Diagnostics - Fine-needle-aspiration biopsies ease the study of liver lymphocytes
Drug Development - Intellectual property licensed for MicroRNA gene involved in hepatitis C
Enzymology - Enzyme wanes in peripheral lymphocytes of patients with viral hepatitis
Enzymology - Hepatitis C virus NS2/3 processing is critical for replication
Finance - Immunotherapy company raises more than $34M in series B financing
Head & Neck Cancers - Lamivudine averts recurrent hepatitis B in patients with nasopharyngeal cancer
Hepatitis B Virus - Telbivudine has the potential to treat patients with chronic hepatitis B
Hepatitis C Therapy - Hepatitis C genotype 3 infection warrants longer treatment regimens
Hepatitis C Therapy - Virology at 12 weeks marks hepatitis C response to pegylated interferon alpha
Hepatitis C Vaccine Development - Hepatitis C virus-host interactions examined
Hepatitis C Virus - Biotech company announces research collaboration with medical college
Hepatitis C Virus - Pegasys plus Ribavirin awarded priority review status by Japanese agency
Hepatitis C Virus - Renin-angiotensin system polymorphisms are not linked to HCV-related fibrosis
Hepatitis C Virus - Therapy elicits changes in liver metallothionein in chronic hepatitis C
Patents - U.S. patent granted covering therapeutic products to treat hepatitis B virus
Stem Cell Research - Fetal liver stem cells are converted into insulin-producing cells
Stem Cell Research - UCB SCs generate cytokeratin 18-negative hepatocyte-like cells in injured liver
Tissue Engineering - Tissue-engineered patch reconstructs inferior vena cava during liver transplant
Transplant Medicine - Whole fetal liver transplantation is an approach to cell therapy
Virology - Hepatitis B core promoter mutations intensify liver disease
Virology - Viral load is valuable for assessing patient response to hepatitis C therapy
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
